Cambridge Investment Research Advisors, Inc. Pacira Bio Sciences, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 29, 2020	SELL	$51.97 - $63.0 $229,707 - $278,460	-4,420 Closed	0 $0
Q2 2020 Jul 27, 2020	SELL	$30.8 - $52.47 $111,126 - $189,311	-3,608 Reduced 44.94%	4,420 $231,000
Q1 2020 May 08, 2020	BUY	$28.4 - $50.7 $69,580 - $124,215	2,450 Added 43.92%	8,028 $269,000
Q4 2019 Feb 04, 2020	SELL	$36.31 - $46.83 $37,254 - $48,047	-1,026 Reduced 15.54%	5,578 $252,000
Q3 2019 Nov 06, 2019	BUY	$35.66 - $44.99 $6,597 - $8,323	185 Added 2.88%	6,604 $251,000
Q1 2019 May 08, 2019	BUY	$36.47 - $42.17 $16,302 - $18,849	447 Added 7.48%	6,419 $0
Q4 2018 Feb 05, 2019	SELL	$41.31 - $52.16 $26,892 - $33,956	-651 Reduced 9.83%	5,972 $256,000
Q3 2018 Nov 02, 2018	BUY	$32.85 - $52.0 $217,565 - $344,396	6,623 New	6,623 $0

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account